Magill Henry H P, Hajibandeh Shahab, Bennett James, Campbell Nathan, Mehta Jaysheel
Registrar, Department of Trauma and Orthopaedic Surgery, Chelsea and Westminster Hospital, London, UK.
Registrar, Department of General Surgery, Salford Royal Foundation Trust, Manchester, UK.
J Foot Ankle Surg. 2019 Mar;58(2):328-332. doi: 10.1053/j.jfas.2018.08.061.
This study aims to compare outcomes of open reduction and internal fixation (ORIF) and primary arthrodesis in management of Lisfranc injuries. In accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards, a systematic review was carried out. MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled Trials were searched to identify both randomised controlled trials (RCTs) and nonrandomised studies comparing the outcomes of ORIF and primary arthrodesis for Lisfranc injuries. Random- and fixed-effect statistical models were applied to calculate the pooled outcome data. Two RCTs and 3 observational studies were identified, compiling a total of 187 subjects with acute Lisfranc injuries and a mean follow-up duration of 62.3 months. Our results demonstrate that ORIF is associated with a significantly higher need for revision surgery (odds ratio [OR] 6.37, 95% confidence interval [CI] 2.68 to 15.11, p < .0001) and a significantly higher rate of persistent pain (OR 6.29, 95% CI 1.07 to 36.89, p = .04) compared with primary arthrodesis. However, we found no significant difference between the groups in terms of visual analogue scale pain score, American Orthopaedic Foot & Ankle Society functional score, or rates of infection. Separate analysis of RCTs showed that ORIF was associated with a more frequent need for revision surgery (OR 17.56, 95% CI 5.47 to 56.38, p < .00001), higher visual analogue scale pain score (mean difference 2.90, 95% CI 2.84 to 2.96, p < .00001), and lower American Orthopaedic Foot & Ankle Society score (mean difference -29.80, 95% CI -39.82 to -19.78, p < .00001). The results of the current study suggest that primary arthrodesis may be associated with better pain and functional outcomes and lower need for revision surgery compared with ORIF. The available evidence is limited and is not adequately robust to make explicit conclusions. The current literature requires high-quality and adequately powered RCTs.
本研究旨在比较切开复位内固定术(ORIF)与一期关节融合术治疗Lisfranc损伤的疗效。按照系统评价和Meta分析的首选报告项目(PRISMA)声明标准,进行了一项系统评价。检索了MEDLINE、EMBASE、CINAHL和Cochrane对照试验中央注册库,以确定比较ORIF与一期关节融合术治疗Lisfranc损伤疗效的随机对照试验(RCT)和非随机研究。应用随机效应和固定效应统计模型计算汇总结局数据。共纳入2项RCT和3项观察性研究,总计187例急性Lisfranc损伤患者,平均随访时间为62.3个月。我们的结果表明,与一期关节融合术相比,ORIF术后翻修手术的需求显著更高(优势比[OR]6.37,95%置信区间[CI]2.68至15.11,p < 0.0001),持续性疼痛发生率显著更高(OR 6.29,95%CI 1.07至36.89,p = 0.04)。然而,我们发现两组在视觉模拟评分疼痛评分、美国矫形足踝协会功能评分或感染率方面无显著差异。对RCT的单独分析表明,ORIF术后翻修手术的需求更频繁(OR 17.56,95%CI 5.47至56.38,p < 0.00001),视觉模拟评分疼痛评分更高(平均差值2.90,95%CI 2.84至2.96,p < 0.00001),美国矫形足踝协会评分更低(平均差值-29.80,95%CI -39.82至-19.78,p < 0.00001)。本研究结果表明,与ORIF相比,一期关节融合术可能具有更好的疼痛和功能结局,且翻修手术需求更低。现有证据有限,不足以得出明确结论。当前文献需要高质量且样本量充足的RCT。